ClinConnect ClinConnect Logo

Main Menu

Search for Trials
Browse by Condition
For Industry
Blog
Contact Us
Dark Mode
Log in Sign up
Search / Trial NCT06767605

Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)

Launched by ASOCIACIÓN ESPAÑOLA PARA EL ESTUDIO DEL HÍGADO · Jan 6, 2025

Download PDF Apply for Trial

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Cholestatic Genetic Diseases Primary Sclerosing Cholangitis (Psc) Hepatitis Autoimmune Disease Primary Biliary Cholangitis (Pbc) Pfic Tipo 1 Pfic Tipo 2 Pfic Tipo 3 Pfic Tipo 4 Bric Tipo 1 Bric Tipo 2 Alagille Syndrome Rotor Syndrome Dubin Johnson Syndrome Genetic Disease Registry Cholestatic Diseases

ClinConnect Summary

The Spanish Registry of Autoimmune and Cholestatic Liver Diseases, known as ColHai, is a study aimed at understanding the condition of patients in Spain who have specific liver diseases, including autoimmune hepatitis, primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and certain genetic cholestatic diseases. This registry will help researchers gather important information about these conditions to improve patient care and treatment options.

To participate in this study, patients need to have a confirmed diagnosis of one of the conditions mentioned above. The study is currently recruiting participants and is open to all adults aged 65 and older. If you choose to participate, you will be asked to sign an informed consent form, which means you agree to take part in the study after understanding what it involves. Your involvement will contribute valuable information that could benefit others with these liver diseases in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Patients with a confirmed diagnosis for PBC, HAI, PSC, genetic cholestatic disease
  • Exclusion Criteria:
  • • Refusal to sign the informed consent for the study

About Asociación Española Para El Estudio Del Hígado

The Asociación Española para el Estudio del Hígado (AEEH) is a prominent Spanish organization dedicated to advancing research and clinical practice related to liver diseases. Comprising a network of healthcare professionals, researchers, and advocates, the AEEH focuses on promoting education, fostering collaboration, and facilitating groundbreaking clinical trials aimed at improving patient outcomes. By supporting innovative studies and disseminating knowledge, the AEEH plays a critical role in enhancing the understanding and treatment of hepatic conditions, ultimately contributing to the advancement of liver health in Spain and beyond.

Locations

Barcelona, , Spain

Patients applied

PR

1 patients applied

Trial Officials

Maria Carlota Londoño Londoño

Study Director

Asociación Española para el Estudio del Hígado

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported